Fortrea Holdings Inc.NASDAQ: FTRE

Fortrea to Participate in September Investor Conferences

· Issued by Fortrea Holdings Inc. via GlobeNewswire

Summary by 6ix AI

Fortrea, a contract research organization (a company that runs clinical trials and related services for drug and medical device makers), said CEO Anshul Thakral, CFO Jason Knoblauch and SVP of Investor Relations Tracy Krumme will take part in three investor conferences in September 2026.

Key details

  • Baird 2026 Global Healthcare Conference (NYC), Tuesday, September 15, 2026: fireside chat from 2:00 to 2:30 PM EDT, plus one-on-one and group meetings. A live webcast and replay of the fireside chat will be available in the Events section of Fortrea's Investor Relations website.
  • Deutsche Bank 2026 Healthcare Summit (NYC), Wednesday, September 16, 2026: one-on-one and group meetings.
  • RBC Pharma Services and Life Science Tools Virtual Conference, Tuesday, September 22, 2026: one-on-one and group meetings.

6ix AI wrote this summary from the release below and checked it against the release.

DURHAM, N.C., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization ("CRO"), today announced that CEO Anshul Thakral, CFO Jason Knoblauch, and SVP of Investor Relations, Tracy Krumme will participate in the following conferences in September:

Baird 2026 Global Healthcare Conference (NYC)

Date: Tuesday, September 15, 2026
Format: Fireside Chat & 1x1 and Group Meetings
Time: 2:00 -2:30 PM EDT
Webcast: FTRE Baird Webcast

Deutsche Bank 2026 Healthcare Summit (NYC)

Date: Wednesday, September 16, 2026
Format: 1x1 and Group Meetings

RBC Pharma Services and Life Science Tools Virtual Conference

Date: Tuesday, September 22, 2026
Format: 1x1 and Group Meetings

The live webcast and replay of the Baird fireside chat will be accessible through the "Events" section of Fortrea's Investor Relations website. Investors interested in meeting with management should contact their banking representatives.

About Fortrea

Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, biotechnology, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients. Fortrea provides phase I-IV clinical trial management, clinical pharmacology and consulting services. Fortrea's solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team working in 100 countries is scaled to deliver focused and agile solutions to clients globally. Learn more about how Fortrea is streamlining drug development at Fortrea.com and follow us on LinkedIn, X and Bluesky.

Fortrea Contacts

Tracy Krumme (Investors) – 984-385-6707, [email protected]
Sue Zaranek (Media) – 919-943-5422, [email protected]
Kate Dillon (Media) – 646-818-9115, [email protected]

Fortrea Holdings Inc. on 6ix

Story so far

Earlier from Fortrea

Later from Fortrea

All Fortrea news releases